Abstract
Background The genetic and environmental aetiology of autistic and Attention Deficit Hyperactivity Disorder (ADHD) traits is known to vary spatially, but does this translate into variation in the association of specific common genetic variants?
Methods We mapped associations between polygenic scores for autism and ADHD and their respective traits in the Avon Longitudinal Study of Parents and Children (N=4,255 to 6,165) across the area surrounding Bristol, UK, and compared them to maps of environments associated with the prevalence of autism and ADHD.
Results Our maps suggest genetic associations vary spatially, with consistent patterns for autistic traits across polygenic scores constructed at different p-value thresholds. Patterns for ADHD traits were more variable across thresholds. We found that the spatial distributions often correlated with known environmental influences.
Conclusions These findings shed light on the factors that contribute to the complex interplay between the environment and genetic influences in autism and ADHD traits.
Key points
The prevalence of autism and ADHD vary spatially.
Our study highlights that genetic influences based on PGS also vary spatially.
This spatial variation correlates with spatial variation in environmental characteristics as well, which would be interesting to examine further.
Our findings have implications for future research in this area examining the factors that contribute to the complex interplay between the environment and genetic influences on autistic and ADHD traits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (Grant ref: MC_UU_00011/1). The UK Medical Research Council and Wellcome Trust (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and ZER and OSPD will serve as guarantors for the contents of this paper. A comprehensive list of grant funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). AB and RT were funded by the Natural Environment Research Council (Grant ref: R8/H12/83/NE/P01830/1) and the Medical Research Council (Grant ref: MC_PC_17210). ZER was supported by a Wellcome Trust PhD studentship (Grant ref: 109104/Z/15/Z). GWAS data for children were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. OSPD is funded by the Alan Turing Institute under the EPSRC (Grant ref: EP/N510129/1). This study was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol (BRC-1215-2011).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (University of Bristol)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated text
Data Availability
Data availability ALSPAC data access is through a system of managed open access. Access can be applied for as detailed in the ALSPAC access policy. Code availability The analysis code used in this study is available upon request from the authors.
